PartnershipJul 20, 2026, 07:01 AM
Iridex Expands EyeProGPO Offering with EndoProbe Handpieces
AI Summary
Iridex Corporation announced the expansion of its EyeProGPO product offering to include its EndoProbe Handpieces. This agreement provides over 4,300 EyeProGPO members with access to preferred pricing on these devices, which are used for treating retinal disorders. The expansion strengthens Iridex's collaboration with EyeProGPO and enhances access to its retina laser portfolio for ophthalmology practices, ambulatory surgery centers, and hospitals across the U.S.
Key Highlights
- Iridex expanded its EyeProGPO product offering to include EndoProbe Handpieces.
- Over 4,300 EyeProGPO members will gain access to preferred pricing on EndoProbe Handpieces.
- The EndoProbe Handpieces are single-use devices for treating retinal disorders.
- This builds on Iridex's existing EyeProGPO offering, which includes PASCAL and Cyclo G6 laser platforms.
- The partnership strengthens collaboration between Iridex and EyeProGPO.
Price Impact
More from IRIX